NCT06430528View on ClinicalTrials.gov

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement

RecruitingOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

August 31, 2027

Conditions
Endogenous Cushing SyndromeAdrenal InsufficiencyHypercortisolism
Interventions
DRUG

Osilodrostat

Add methylprednisolone to osilodrostat therapy after first dose and continue during osilodrostat titration.

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Recordati Rare Diseases

INDUSTRY

lead

University of Michigan

OTHER